Anticorps Monoclonal anti-ICOSLG/B7-H2/CD275

ICOSLG/B7-H2/CD275 Monoclonal Antibody for WB, Indirect ELISA

Hôte / Isotype

Mouse / IgG2a

Réactivité testée

Humain

Applications

WB, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2G1F8

N° de cat : 67003-1-PBS

Synonymes

B7H2, ICOSLG, B7RP1, B7-related protein 1, B7-like protein Gl50



Informations sur le produit

67003-1-PBS cible ICOSLG/B7-H2/CD275 dans les applications de WB, Indirect ELISA et montre une réactivité avec des échantillons Humain

Réactivité Humain
Hôte / Isotype Mouse / IgG2a
Clonalité Monoclonal
Type Anticorps
Immunogène ICOSLG/B7-H2/CD275 Protéine recombinante Ag6799
Nom complet inducible T-cell co-stimulator ligand
Masse moléculaire calculée 33 kDa, 34 kDa
Poids moléculaire observé 60-65 kDa, 28-35 kDa
Numéro d’acquisition GenBankBC064637
Symbole du gène ICOSLG
Identification du gène (NCBI) 23308
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

ICOSLG, also known as B7H2 or GL50, is a type I transmembrane glycoprotein belonging to the B7 ligand family. ICOSLG is extensively expressed on professional antigen-presenting cells including B cells, macrophages, and dendritic cells, as well as non-lymphoid cells including mesenchymal stem cells, endothelial cells, fibroblasts, and tumor cells (PMID: 33756276; 35800767). It is a specific ligand for the T-cell-specific cell surface receptor ICOS and acts as a co-stimulatory molecule (PMID: 11023515; 11007762). The interaction of ICOSLG and ICOS plays important roles in the activation, proliferation, differentiation, and cytokine production of T cells as well as in the antibody secretion from B cells during secondary immune responses (PMID: 21851236).

{{ptg:RelatedPrimaryAntibodies}}